Placental protein 5 is related to blood coagulation and fibrinolytic systems.
Previous studies have shown that placental protein 5 (PP5) forms complexes with heparin. In order to further elucidate the biological role of PP5 we studied the effect of plasmin and thrombin on the immunoreactivity of PP5, and the possible functional antiplasmin and antithrombin effects of purified PP5. Varying concentrations of plasmin and thrombin were added to pregnancy plasma, and the PP5 levels, measured by radioimmunoassay, were found to be elevated by 558% (plasmin and 48-87% (thrombin). Incubation of radiolabeled PP5 with plasmin resulted in the formation of radioactive fragments with smaller molecular weights. Functional studies using a chromogenic substrate confirmed that purified PP5 has an antiplasmin activity. An average increase of 15% was observed in the antiplasmin activity when 200 ng purified PP5 was added to 150 microliters of pregnancy serum. Thus, there are certain similarities between PP5 and antihrombin III. Both form complexes with heparin and have antiplasmin properties, and both were found to be heat labile. But, functional studies utilizing a chromogenic substrate failed to demonstrate any antithrombin III-like activity in the purified PP5 preparation that had antiplasmin activity. Our results show that the function of PP5 is related to the blood coagulation and fibrinolytic systems, at least through its inhibitory action on plasmin.
D000990:Antithrombin III / Q000378:metabolism; D001777:Blood Coagulation; D005260:Female; D005341:Fibrinolysin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D005342:Fibrinolysis; D006023:Glycoproteins; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000097:blood*; D013917:Thrombin / Q000378:metabolism*
D006023:Glycoproteins; D011257:Pregnancy Proteins; C021240:tissue-factor-pathway inhibitor 2; D000990:Antithrombin III; D006493:Heparin; D013917:Thrombin; D005341:Fibrinolysin